At AthemBio we are a team of passionate innovators dedicated to tackling the toughest challenges in bioprocessing. We are a private company headquartered in Research Triangle Park North Carolina and our mission is to transform groundbreaking technologies into practical solutions that empower the future of healthcare.
Our Approach:
We understand the critical role bioprocessing plays in the development of life-saving therapies and treatments. That’s why we focus on delivering:
- Automated Continuous Solutions: We design and develop automated systems for continuous centrifugation chromatography and cell lysis/homogenization streamlining workflows and improving efficiency.
- Single-Use Technologies: Our commitment to single-use assemblies ensures aseptic processing which reduces the risk of contamination. It also reduces capital costs and turnaround times.
- Scalable Systems: Our solutions are designed to adapt and grow alongside your needs offering flexibility for research and large-scale production.
- Unparalleled Support: We back our products with exceptional services to ensure you get the most out of your AthemBio solutions.
Driven by Experience:
Through collaboration with global customers we have gained a deep understanding of the real-world challenges faced in bioprocessing. We leverage this experience to develop solutions that are not only innovative but also:
- Simple to Implement: Our user-friendly systems are designed for ease of use minimizing training requirements.
- Robust and Reliable: We prioritize durability and dependability ensuring consistent performance for critical tasks.
At AthemBio we are committed to being your partner in bioprocessing success. We are here to help you overcome challenges accelerate progress and deliver life-saving therapies to the world.
AthemBio is guided by the vision of Dr. Sunil Mehta our CEO. Dr. Mehta is a scientist inventor and global entrepreneur with over 25 years of experience in biopharmaceuticals cell and gene therapy and vaccines.
A proven leader Dr. Mehta has a successful track record of transforming innovative technologies into high-quality products. He is a champion of efficient outsourcing strategies allowing AthemBio to focus its expertise on core R&D activities and customer support. Dr. Mehta’s experience is vast spanning leadership and scientific roles at KBI Biopharma Johnson & Johnson and Roche. He possesses a deep understanding of the entire bioprocessing workflow from R&D to commercial cGMP manufacturing of biologics.
Dr. Mehta’s entrepreneurial spirit is evident in his co-founding of kSep Systems in 2011. As President and CEO he spearheaded kSep’s remarkable growth transforming it into a global leader before its successful acquisition by Sartorius Stedim Biotech in 2016.
Dr. Mehta holds a Ph.D. from Brown University and gained valuable early research experience at the Uniformed Services University of the Health Sciences. His expertise is further bolstered by several key patents in diverse bioprocessing technologies and cancer therapies.
Dr. Mehta’s leadership and vision are instrumental in driving AthemBio’s commitment to developing innovative bioprocessing solutions that empower advancements in healthcare.